Association of a pre-miR-27a polymorphism with cancer risk: an updated meta-analysis

Rong-Pan Bai1, Yu Weng, Li-Ling Su

  • 1Institute of Environmental Health, Zhejiang Univerisity School of Medicine, Hangzhou, China E-mail : chenguangdi@gmail.com or llq199@yahoo.com.cn.

Insights

This meta-analysis found no overall association between the pre-microRNA-27a (miR-27a) rs895819 genetic variant and cancer risk. However, the G allele of this polymorphism showed a protective effect against cancer in Caucasians, particularly in breast cancer cases.

Area of Science:

  • Genetics
  • Oncology
  • Molecular Biology

Background:

  • MicroRNA-27a (miR-27a) is an oncogenic microRNA frequently overexpressed in various cancers.
  • A known genetic variant in pre-miR-27a, rs895819 (A>G), has been investigated for its association with cancer risk, but existing study results are conflicting.

Purpose of the Study:

  • To conduct a meta-analysis to clarify the association between the pre-miR-27a rs895819 polymorphism and cancer susceptibility.
  • To provide a more precise estimation of the risk conferred by this genetic variant.

Main Methods:

  • A comprehensive literature search was performed in PubMed and other databases up to March 2014.
  • Seventeen case-control studies comprising 7,813 cancer cases and 9,602 controls were included in the meta-analysis.
  • Crude odds ratios (ORs) and 95% confidence intervals (CIs) were calculated to assess the association between rs895819 and cancer risk.

Main Results:

  • The overall meta-analysis revealed no significant association between the rs895819 polymorphism and overall cancer susceptibility, including in Asian populations.
  • In Caucasian populations, the rs895819 polymorphism was associated with a reduced cancer risk under heterozygous and dominant models.
  • The G allele of rs895819 demonstrated a protective effect against cancer in Caucasians (OR, 0.90; 95% CI, 0.84-0.97), with a significant association observed for decreased breast cancer risk (OR, 0.91; 95% CI, 0.85-0.98).

Conclusions:

  • The pre-miR-27a rs895819 polymorphism is associated with cancer risk in Caucasian populations.
  • The G allele of rs895819 exhibits a protective effect, particularly in breast cancer, younger patients, and unilateral cases, though further confirmation is needed due to study limitations.

Related Concept Videos

Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
8.7K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.4K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
25.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.4K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
10.2K